All lobbying filings

VENABLE LLP

Lobbying for DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA · Non-profit product development partnership

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 14, 2026

Income

$10,000.00

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Budget/Appropriations

FY 2026 & FY 2027 Labor, Health and Human Services, Education and State and Foreign Operations funding for global health research and development and neglected tropical diseases; FY 2026 & FY 2027 global health research and development funding; Issues related to global health.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.